Apple, Chevron, Biogen fall premarket; Univar, Pinduoduo rise
- Nasdaq, S&P tumble as Netflix, chip stocks drag; AmEx boosts Dow
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Wall St indexes split, Treasuries dip amid earnings, geopolitical crosscurrents
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Jabil falls after placing CEO on paid leave amid internal investigation
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
Pinduoduo Inc. (PDD) PT Raised to $107 at Goldman Sachs
November 28, 2022 5:21 PM ESTGoldman Sachs analyst Ronald Keung raised the price target on Pinduoduo Inc. (NASDAQ: PDD) to $107.00 (from $95.00) while maintaining a Buy rating following earnings.
The analyst commented, "Factoring in strong 3Q results, we lift our revenue estimates by +8% to +12% and adj. operating profit... More
Apple (AAPL) threatened to withhold Twitter from App Store says Musk
November 28, 2022 4:26 PM ESTElon Musk said in a series of tweets on Monday that Apple (NASDAQ: AAPL) threatened to withhold Twitter from its App Store without providing a reason why.
The Twitter owner and Tesla CEO tweeted: "Apple has also threatened to withhold Twitter from its App Store, but won't tell us... More
Sony to supply state-of-the-art image sensors for the next Apple (AAPL) iPhone - Nikkei
November 28, 2022 3:21 PM EST(Updated - November 28, 2022 3:22 PM EST)
The next Apple (NASDAQ: AAPL) iPhone series will be equipped with Sony Group's latest state-of-the-art image sensor, according to a report by Nikkei on Monday.
The sensor will be supplied to Apple... More
Recession impacts on Williams-Sonoma (WSM) 'appear underestimated'
November 28, 2022 2:06 PM ESTRetailer Williams-Sonoma (NYSE: WSM) was cut to Underweight from Equal-Weight by Morgan Stanley analyst Simeon Gutman on Monday, also lowering the firm's price target on the stock to $100 per share from $150.
Gutman told investors in a research note that earnings revisions could turn sharply negative in 2023 as the "impacts of reversion, recession & normalizing promotions appear... More
Pinduoduo Inc. (PDD) PT Raised to $85 at US Tiger Securities
November 28, 2022 11:39 AM ESTUS Tiger Securities analyst Bo Pei raised the price target on Pinduoduo Inc. (NASDAQ: PDD) to $85.00 (from $80.00) while maintaining a Buy rating following earnings.
The analyst commented, "We are maintaining our BUY rating and raising our price target to $85 (was $80) after PDD beat 3Q revenue and profit estimates by a wide margin with... More
Univar (UNVR) Could Be Seeking a Takeover at $40/Share Plus - Deutsche Bank
November 28, 2022 11:22 AM ESTDeutsche Bank analyst David Begleiter weighed in on Univar Solutions Inc. (NYSE: UNVR) after the company confirmed that it has received a preliminary indication of interest from Brenntag SE regarding a potential takeover.
Begleiter believes Univar could be seeking an acquisition price of... More
Biogen (BIIB) Stock Falls on Alzheimer's Drug Trial Death Reports
November 28, 2022 10:05 AM ESTBiogen (NASDAQ: BIIB) shares dipped Monday after a report by Science.org stated that a woman participating in a trial of experimental Alzheimer's treatment lecanemab had recently died from a brain hemorrhage.
According to the report, some researchers linked the brain hemorrhage to the drug. It is said to be the second death thought to be associated with lecanemab,... More
Truist Securities Weighs in on Biogen (BIIB) Following 2nd Reported Alzheimer's Death
November 28, 2022 9:26 AM ESTTruist Securities analyst Robyn Karnauskas weighed in on Biogen (NASDAQ: BIIB) following recent news of the second death reported for Alzheimer's drug lecanemab. The analyst highlights:
The recent news and AEs of the drug raise lots of questions whether... More